in this issue
Regions :: Western Europe :: Germany
Evonik advances biotech investments
9:18 AM MDT | October 9, 2012 | Sotirios Frantzanas
Evonik says that it plans to continue expanding its commitment to biotech as explores opportunities for profitable growth in a range of business areas. Biotech gives "Evonik's growth strategy a stronger focus on sustainable development. In the health and nutrition business unit alone we are hoping for sales of €1 billion ($1.29 billion) over the medium term for products made using biotech," says Patrik Wohlhauser, member of Evonik's executive board. Evonik will be investing about €350 million by 2014 to expand its Biolys business, an amino...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee